|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.00 TWD | +1.42% |
|
+0.53% | +6.45% |
| Market Cap | 11.2B 347M 300M 280M 257M 484M 33.02B 491M 3.29B 1.29B 16.55B 1.3B 1.27B 54.71B | P/E 2024 |
12.6x | P/E 2025 | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.77B 302M 262M 244M 224M 422M 28.79B 428M 2.87B 1.13B 14.43B 1.14B 1.11B 47.7B | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.29x |
| Free-Float |
44.21% | Yield 2024 |
4.52% | Yield 2025 | 3.4% |
| 1 day | +1.42% | ||
| 1 week | +0.53% | ||
| Current month | +0.53% | ||
| 1 month | -1.42% | ||
| 3 months | +2.62% | ||
| 6 months | +2.96% | ||
| Current year | +6.45% |
| 1 week | 55.8 |  | 57.3 |
| 1 month | 55.7 | | 59 |
| Current year | 53.55 | | 60.55 |
| 1 year | 48.64 | | 60.55 |
| 3 years | 46.55 | | 72.18 |
| 5 years | 33.45 | | 72.36 |
| 10 years | 24.86 | | 72.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tzu Ting Fan
CEO | Chief Executive Officer | - | 30/05/2006 |
Reynold Hsu
DFI | Director of Finance/CFO | - | 16/07/2019 |
Wei Jen Chen
PRN | Corporate Officer/Principal | - | 01/04/2001 |
| Director | Title | Age | Since |
|---|---|---|---|
Chin Tsai Fan
CHM | Chairman | - | 30/06/1967 |
Yuan Te Li
BRD | Director/Board Member | - | 06/06/2012 |
Tsui Wen Yeh
BRD | Director/Board Member | - | 29/05/2002 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.42% | +0.53% | +14.00% | +2.45% | 347M | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +1.16% | +0.80% | +31.78% | +40.12% | 362.11B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.72% | +64.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.79B 210M 182M 170M 156M 293M 20.01B 298M 1.99B 782M 10.03B 789M 772M 33.15B | 7.02B 217M 188M 176M 161M 303M 20.7B 308M 2.06B 809M 10.37B 817M 799M 34.3B |
| Net income | 881M 27.27M 23.58M 22.02M 20.2M 38M 2.59B 38.6M 258M 101M 1.3B 102M 100M 4.3B | 928M 28.73M 24.85M 23.2M 21.29M 40.04M 2.73B 40.67M 272M 107M 1.37B 108M 106M 4.53B |
| Net Debt | -1.24B -38.51M -33.31M -31.11M -28.53M -53.67M -3.66B -54.52M -365M -143M -1.84B -145M -141M -6.07B | -1.44B -44.47M -38.47M -35.92M -32.96M -61.99M -4.23B -62.97M -421M -165M -2.12B -167M -163M -7.01B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | NT$57.00 | +1.42% | 233,263 |
| 06/08/26 | NT$56.20 | -0.71% | 839,367 |
| 05/08/26 | NT$56.60 | +0.35% | 347,474 |
| 04/08/26 | NT$56.40 | -0.88% | 290,976 |
| 03/08/26 | NT$56.90 | +0.35% | 289,360 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1720 Stock
Select your edition
All financial news and data tailored to specific country editions
